Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Short term Debt: 2021-2024

Historic Short term Debt for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Dec 2024 value amounting to $4.9 million.

  • ProQR Therapeutics N.V's Short term Debt was N/A to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2024, which is N/A change from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Short term Debt stood at $4.9 million for FY2024, which was up 91.97% from $2.6 million recorded in FY2022.
  • Over the past 5 years, ProQR Therapeutics N.V's Short term Debt peaked at $5.6 million during FY2021, and registered a low of $2.6 million during FY2022.
  • Moreover, its 2-year median value for Short term Debt was $3.7 million (2022), whereas its average is $3.7 million.
  • Data for ProQR Therapeutics N.V's Short term Debt shows a maximum YoY crashed of 54.82% (in 2022) over the last 5 years.
  • Over the past 3 years, ProQR Therapeutics N.V's Short term Debt (Yearly) stood at $5.6 million in 2021, then crashed by 54.82% to $2.6 million in 2022, then reached $4.9 million in 2024.